Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Status unconfirmed · Not applicable

Conditions studied: Fallopian Tube Cancer, Ovarian Cancer

In brief

RATIONALE: Finding specific proteins in the blood may help doctors tell whether a patient has ovarian cancer. PURPOSE: This clinical trial is studying how well proteomic profiling works in diagnosing ovarian cancer in patients who are undergoing surgery for an abnormal pelvic mass.

Key facts

Study ID

NCT00238342

Run by

Gynecologic Oncology Group

People needed

2000

Starts

2005-10-01

Last updated by the study team

2010-02-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Highlands Oncology Group - Fayetteville — Fayetteville, Arkansas, United States
• Washington Regional Medical Center — Fayetteville, Arkansas, United States
• Providence Saint Joseph Medical Center - Burbank — Burbank, California, United States
• Kaiser Permanente Medical Center - Los Angeles — Los Angeles, California, United States
• Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
• Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center — Orange, California, United States
• George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus — New Britain, Connecticut, United States
• Beebe Medical Center — Lewes, Delaware, United States
• CCOP - Christiana Care Health Services — Newark, Delaware, United States
• Florida Gynecologic Oncology - Fort Myers — Fort Myers, Florida, United States
• Lakeland Regional Cancer Center at Lakeland Regional Medical Center — Lakeland, Florida, United States
• Bayfront Medical Center — St. Petersburg, Florida, United States
• Northwest Community Hospital — Arlington Heights, Illinois, United States
• Rush-Copley Cancer Care Center — Aurora, Illinois, United States
• Hinsdale Hematology Oncology Associates — Hinsdale, Illinois, United States
• Joliet Oncology-Hematology Associates, Limited - West — Joliet, Illinois, United States
• Chicago Gynecologic Oncology — Palatine, Illinois, United States
• Carle Cancer Center at Carle Foundation Hospital — Urbana, Illinois, United States
• CCOP - Carle Cancer Center — Urbana, Illinois, United States
• Elkhart General Hospital — Elkhart, Indiana, United States
• St. Vincent Indianapolis Hospital — Indianapolis, Indiana, United States
• Howard Community Hospital at Howard Regional Health System — Kokomo, Indiana, United States
• Center for Cancer Therapy at LaPorte Hospital and Health Services — La Porte, Indiana, United States
• Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.